Back to search

Article

High-throughput RNAi screen identifies ILK as a target to overcome intrinsic EGFR-TKI resistance of lung squamous carcinoma

2019-11-19

Abstract excerpt

<title>Abstract</title> <p>Although targeted therapy has made a significant efficacy in lung adenocarcinoma, there are still no effective targeted drugs for lung squamous cell carcinoma (SqCC). Moreover, immunotherapy only prolonged the OS of lung SqCC for less than 5 months, so till now, chemotherapy and radiotherapy are still the main treatments of advanced SqCC. Lung SqCC patients express higher epithelial gro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1ddd1697-df1b-53ee-8fd0-142e6b63b680
DOI
10.21203/rs.2.17492/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High-throughput RNAi screen identifies ILK as a target to overcome intrinsic EGFR-TKI resistance of lung squamous carcinomaDOI 10.21203/rs.2.17492/v1
Select a neighboring publication to make it the new centre.